These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 7927488)

  • 21. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.
    Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q
    J Allergy Clin Immunol; 1997 Oct; 100(4):569-74. PubMed ID: 9338554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
    Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
    J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of mucosal inflammation in the nose and lungs.
    Durham SR
    Clin Exp Allergy; 1998 Jun; 28 Suppl 2():11-6. PubMed ID: 9678822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
    Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
    J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis.
    Malmhäll C; Bossios A; Pullerits T; Lötvall J
    Allergy; 2007 Sep; 62(9):1007-13. PubMed ID: 17686103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids.
    Wright ED; Christodoulopoulos P; Small P; Frenkiel S; Hamid Q
    Laryngoscope; 1999 Apr; 109(4):551-6. PubMed ID: 10201739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein.
    Powell N; Till SJ; Kay AB; Corrigan CJ
    Clin Exp Allergy; 2001 Jan; 31(1):69-76. PubMed ID: 11167953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
    Benson M; Strannegård IL; Strannegård O; Wennergren G
    J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical efficacy of grass-pollen immunotherapy.
    Durham SR; Walker SM; Varga EM; Jacobson MR; O'Brien F; Noble W; Till SJ; Hamid QA; Nouri-Aria KT
    N Engl J Med; 1999 Aug; 341(7):468-75. PubMed ID: 10441602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed.
    Dolovich J; O'Connor M; Stepner N; Smith A; Sharma RK
    Ann Allergy; 1994 May; 72(5):435-40. PubMed ID: 8179230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis.
    Dolovich J; Wong AG; Chodirker WB; Drouin MA; Hargreave FE; Hebert J; Knight A; Small P; Yang WH
    Ann Allergy; 1994 Aug; 73(2):147-53. PubMed ID: 8067598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of fluticasone propionate topically dosed prior to the pollen scattering season on cellular infiltration into the surface of nasal mucous membrane in patients with Japanese cedar pollinosis].
    Onishi M; Suihou X; Okubo K; Ikeda M; Yokoshima K; Okuda M
    Arerugi; 1993 Mar; 42(3 Pt 1):228-35. PubMed ID: 8498894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
    Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
    Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.